These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17499937)

  • 1. Botulinum toxin, Quo Vadis?
    Lim EC; Seet RC
    Med Hypotheses; 2007; 69(4):718-23. PubMed ID: 17499937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can botulinum toxin put the restless legs syndrome to rest?
    Lim EC; Seet RC
    Med Hypotheses; 2007; 69(3):497-501. PubMed ID: 17363179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New therapeutic indications for botulinum toxins.
    Cordivari C; Misra VP; Catania S; Lees AJ
    Mov Disord; 2004 Mar; 19 Suppl 8():S157-61. PubMed ID: 15027069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin: historical perspective and potential new indications.
    Jankovic J; Brin MF
    Muscle Nerve Suppl; 1997; 6():S129-45. PubMed ID: 9826986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin: a deadly substance with great therapeutic effect.
    Holmes S
    Prof Nurse; 2003 Oct; 19(2):85-7. PubMed ID: 14593781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injectable neuromodulatory agents: botulinum toxin therapy.
    Frenkl TL; Rackley RR
    Urol Clin North Am; 2005 Feb; 32(1):89-99. PubMed ID: 15698881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin: clinical use.
    Truong DD; Jost WH
    Parkinsonism Relat Disord; 2006 Sep; 12(6):331-55. PubMed ID: 16870487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of action and therapeutic uses of botulinum and tetanus neurotoxins].
    Popoff MR; Marvaud JC; Raffestin S
    Ann Pharm Fr; 2001 May; 59(3):176-90. PubMed ID: 11427819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with botulinum neurotoxin of gastrointestinal smooth muscles and sphincters spasms.
    Brisinda G; Bentivoglio AR; Maria G; Albanese A
    Mov Disord; 2004 Mar; 19 Suppl 8():S146-56. PubMed ID: 15027068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin in movement disorders.
    Papapetropoulos S; Singer C
    Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological effects of botulinum toxin in spasticity.
    Gracies JM
    Mov Disord; 2004 Mar; 19 Suppl 8():S120-8. PubMed ID: 15027064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin: treatment of self-mutilation in patients with Lesch-Nyhan syndrome.
    Gutierrez C; Pellene A; Micheli F
    Clin Neuropharmacol; 2008; 31(3):180-3. PubMed ID: 18520986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
    Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
    Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin and hemorrhoids.
    Cadeddu F; Brisinda G; Maria G
    Dis Colon Rectum; 2006 Nov; 49(11):1799-800; author reply 1800-1. PubMed ID: 16988852
    [No Abstract]   [Full Text] [Related]  

  • 15. Children undergoing treatment with botulinum toxin: the role of the physical therapist.
    Leach J
    Muscle Nerve Suppl; 1997; 6():S194-207. PubMed ID: 9826991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related botulinum toxin effects on muscle fiber conduction velocity in non-injected muscles.
    Lange F; van Weerden TW; van der Hoeven JH
    Clin Neurophysiol; 2007 Nov; 118(11):2398-403. PubMed ID: 17897878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Where has all the botox gone? (how) will we ever learn... using monoclonal antibodies to track botulinum toxin.
    Lim EC; Oh VM; Ong BK; Chow AW; Seet RC
    Med Hypotheses; 2006; 67(3):440-6. PubMed ID: 16678355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential.
    Meng J; Wang J; Lawrence G; Dolly JO
    J Cell Sci; 2007 Aug; 120(Pt 16):2864-74. PubMed ID: 17666428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New applications of botulinum toxin].
    López del Val LJ; Morales Asín F
    Neurologia; 1998 Oct; 13(8):388-94. PubMed ID: 9859671
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term botulinum toxin treatment increases employment rate in patients with cervical dystonia.
    Skogseid IM; Røislien J; Claussen B; Kerty E
    Mov Disord; 2005 Dec; 20(12):1604-9. PubMed ID: 16114026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.